Shire pharmaceutical valued at £30bn in new AbbVie bid – The Guardian


The Guardian
Shire pharmaceutical valued at £30bn in new AbbVie bid
The Guardian
Pharmaceutical company Shire has been valued at £30bn in a raised bid from the US rival which has been trying to take control of the business for weeks. The chairman of Chicago-based AbbVie urged Shire shareholders to back its fourth offer for the FTSE …
In Pursuit of Shire, AbbVie Eyes Lower Taxes in UKFox Business
AbbVie Pushes Shire Bid Over $51 BillionForbes
AbbVie Inc Ups Bid for Shire PLC (ABBV, SHPG)Dividend.com

all 142 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd